Antimicrobial Agents and Chemotherapy 2013-04-01

Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection.

Mairi Ziaka, Sophia L Markantonis, Marizoza Fousteri, Paris Zygoulis, Dimitris Panidis, Marios Karvouniaris, Demosthenes Makris, Epaminondas Zakynthinos

文献索引：Antimicrob. Agents Chemother. 57(4) , 1938-40, (2013)

全文：HTML全文

摘要

Colistin pharmacokinetics were prospectively studied after intravenous administration of colistin methanesulphonate in critically ill patients without central nervous system infection (controls, n = 5) and in patients with external ventricular drain-associated ventriculitis after intravenous administration (EVDViv, n = 3) or combined intravenous/intraventricular administration (EVDVcomb, n = 4). Cerebrospinal fluid (CSF)/serum colistin concentration ratios were higher in EVDViv than in control patients (11% versus 7%, P ≤ 0.05) and in EVDVcomb compared to all other patients (P < 0.0001). CSF colistin concentrations above the MIC of 0.5 μg/ml were achieved only in EVDVcomb patients.